Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOST: SIMPLE vs STEPWISE - IDegAsp Titration in T2DM
NCT01680341Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2012
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of insulin degludec + insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Aug 2012; status: completed.
02
Drugs
insulin degludec + insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01680341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680341.